Central-boost Ablative Radiation Therapy for Solid Tumors: Study Protocol of a Single-arm, Phase II Trial (CBART)
Background Though stereotactic body radiation therapy (SBRT) has been widely used in advanced tumors, ablative doses may not be appropriate in the case of large tumors or those abutting to the gastrointestinal tracts, resulting in unfavorable outcomes. Therefore, partial irradiation with high doses...
Saved in:
| Main Authors: | Lingong Jiang MD, Yangsen Cao MD, Xiaolan Yin MD, Chunshan Yu MD, Yusheng Ye MD, Xiaofei Zhu MD, Huojun Zhang MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | Technology in Cancer Research & Treatment |
| Online Access: | https://doi.org/10.1177/15330338251350833 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Simultaneous Integrated Boost Followed by Selective Sequential Boost Radiotherapy for Spinal Metastases: A Single-Arm Retrospective Study
by: Hui Xiao BS, et al.
Published: (2025-08-01) -
Response to Central Boost Radiation Therapy in Unresectable Retroperitoneal Sarcoma: A Case Series
by: Danielle N. Burner, BS, et al.
Published: (2025-02-01) -
Catheter ablation for atrial fibrillation in patients with tricuspid regurgitation
by: Corinne Isenegger, MD, et al.
Published: (2025-08-01) -
A rare tamponade after percutaneous ablation operationCentral Message
by: Yingjie Ke, MD, et al.
Published: (2024-08-01) -
Risk of acute pericarditis after pulsed-field ablation pulmonary vein isolation
by: Juliana Pérez-Pinzón, MD, et al.
Published: (2025-08-01)